HomeOpen Access NewsClinical Trials

Clinical Trials

Early dog exposure may reduce childhood eczema risk

Having a pet dog may lower the risk of eczema in children who are genetically prone to the condition, shedding light on how environmental factors may influence genetic risks.

TheraVision: An oncolytic virus platform technology for a personalised virus-immunotherapy

Prof Dr Susanne M Bailer, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, explains the possibilities of an oncolytic virus platform technology.

Clinical trials begin for three mRNA HIV vaccines

The National Institute of Allergy and Infectious Diseases (NIAID) has launched Phase 1 clinical trials for three mRNA HIV vaccines.

Real-world evidence set to turbo boost personalised healthcare

Richard Armstrong, head of registries at NEC Software Solutions UK, puts real-world evidence under the microscope and examines how, as our population ages it has the power to speed up medical interventions at scale.

New potential therapy for aggressive bladder cancer

Led by Yale Cancer Center, new research shows that enfortumab vedotin is an effective alternative for patients with muscle-invasive bladder cancer (MIBC)

Scientists discover new treatment to fight pancreatic cancer

The potential pancreatic cancer treatment combines an ultrasound and immunotherapy method, with substantial "anti-cancer" benefits in lab mice.

New gene-silencing drug could help with ALS

New research suggests that in suppressing a mutated ALS gene, it may be possible to delay to onset of symptoms.

Early detection of pancreatic cancer – The EUROPAC Research Trial

Dr Deborah Lee, Dr Fox Online Pharmacy, tells us all about the European pancreatic cancer early detection trial (EUROPAC).

Osteogenesis imperfecta – what we need to know

Frost & Sullivan’s TechCasting Group, places the spotlight on osteogenesis imperfecta – toward future targeted, more effective therapy.

Proving the effectiveness of digital health technologies

Professor Freimut Schliess, Director of Science & Innovation, at the Profil Institut für Stoffwechselforschung GmbH, illustrates how dissipating initial scepticism of digital health technologies makes for a thrilling challenge for regulators, manufacturers and clinical researchers alike.

Merck says “COVID pill” can decrease risk of death by 50%

Pharmaceutical company, Merck, have a "COVID pill" at Phase 3 clinical trial - which seems to decrease risk of death by 50%.

NIH funds menstrual cycle and COVID vaccine research

McLean Hospital’s Clinical and Translational Pain Research Laboratory is one of five institutions splitting a $1.67 million NIH grant - the research will examine any links between the menstrual cycle and the COVID vaccine.

What is Osteogenesis Imperfecta (OI)?

Patricia Osborne, Chief Executive of the Brittle Bone Society, tells us what we need to know about Osteogenesis Imperfecta.

Moderna create vaccine trial for children aged 6 months and over

Moderna are enrolling roughly 13,275 participants in their vaccine trial for children - with the participants aged between six months to 12 years.

Study with one million vaccinated people finds AstraZeneca is safe

The study, pre-printed in The Lancet, found that blood clots were far more common in people with COVID-19 than people vaccinated with AstraZeneca.

Immunologists push for more intranasal COVID vaccines

While intramuscular vaccines are the norm right now, immunologists propose that intranasal COVID vaccines would be great for booster shots.

Study finds 97% of women in Africa will work with HIV prevention methods

The REACH study found that 97% of women and girls in Uganda, South Africa and Zimbabwe are happy to work with HIV prevention methods - globally, half of all people living with HIV are women.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders